⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MDCX News
Medicus Pharma Ltd. Common Stock
Medicus Pharma to Present at BioFuture and Global Biotechnology Summit
globenewswire.com
MDCX
Medicus Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
globenewswire.com
MDCX
Form 8-K
sec.gov
MDCXW
MDCX
Form 8-K
sec.gov
MDCXW
MDCX
Medicus Pharma Highlights Three Years of Progress and Outlines Potential Path to Long Term Value
globenewswire.com
MDCX
Form 8-K
sec.gov
MDCX
MDCXW
Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer
globenewswire.com
MDCX
Medicus Pharma Announces Exclusive Development Focus for SkinJect® in Gorlin Syndrome Following Commercial, Clinical and Regulatory Assessment
globenewswire.com
MDCX
Form 8-K
sec.gov
MDCX
MDCXW
Form 8-K
sec.gov
MDCXW
MDCX